GYNECOLOGIC HEALTH CARE 4TH
EDITION COMPLETE TEST BANK — ALL
CHAPTERS 1-35 (LATEST 2026 UPDATE)
This comprehensive practice question pack mirrors
the official test bank structure across all 35
chapters of Gynecologic Health Care: With an
Introduction to Prenatal and Postpartum Care (4th
Edition). Each advanced multiple-choice question
features full diagnostic breakdowns, realistic clinical
scenarios, and bolded rationales targeting key
NCLEX and midwifery certification concepts. It
serves as an essential, high-yield resource for
nursing, nurse-midwifery, and nurse practitioner
students preparing for demanding clinical exams and
board certifications.
1. A 26-year-old female presents for her routine well-woman exam.
She has no significant medical history, no new sexual partners, and
her last cervical cancer screening was 3 years ago with normal
cytology. According to current ASCCP and ACOG guidelines, what
is the most appropriate next step in her cervical cancer screening
, management?
A) Rescreen with cytology alone in 2 years.
B) Screen with co-testing (cytology plus high-risk HPV testing)
today.
C) Screen with primary human papillomavirus (hpv) testing alone
today.
D) Delay all screening until she reaches age 30.
Answer: C
Rationale: For individuals aged 25 to 65, current primary guidelines
recommend screening every 5 years with primary HPV testing alone.
Alternatively, co-testing every 5 years or cytology alone every 3 years
is acceptable. Because she is 26 and her last pap was 3 years ago, she
is due for screening now. Primary HPV testing is preferred by major
clinical bodies due to its higher sensitivity for detecting cervical
intraepithelial neoplasia. Screening should not be delayed until age
30, nor should she wait another 2 years.
2. A 32-year-old G2P1 patient at 28 weeks of gestation presents to
the clinic for a routine prenatal visit. Her blood type is confirmed
as A-negative, and her antibody screen is negative. Her husband’s
blood type is unknown. Which clinical intervention is indicated at
this visit?
A) Administer Rho(D) immune globulin (RhoGAM) 300 mcg
intramuscularly today.
B) Hold RhoGAM until delivery and test the infant’s cord blood
first.
C) Perform a Kleihauer-Betke test to quantify fetal-maternal
hemorrhage before treating.
, D) Administer RhoGAM only if the patient experiences abdominal
trauma or vaginal bleeding.
Answer: A
Rationale: Prophylactic Rho(D) immune globulin (300 mcg) is routinely
administered to all unsensitized Rh-negative pregnant individuals
between 28 and 30 weeks of gestation. This prevents
alloimmunization in case the fetus is Rh-positive. Waiting until
delivery is unsafe because significant silent fetal-maternal
microhemorrhages can occur during the third trimester. A Kleihauer-
Betke test is used to calculate extra dosing after known trauma or
delivery, not for routine prophylaxis. Prophylaxis is standard
regardless of whether overt trauma has occurred.
3. A 53-year-old menopausal patient complains of severe
vulvovaginal burning, dryness, and dyspareunia. Physical
examination reveals pale, thin vaginal mucosa with a loss of
vaginal rugae and a vaginal pH of 6.0. She has no vasomotor
symptoms or systemic medical contraindications. What is the first-
line, gold-standard therapy for this specific condition?
A) Low-dose oral conjugated estrogens.
B) Vaginal moisturizers and water-based lubricants.
C) Topical low-dose vaginal estrogen therapy (cream, tablet, or
ring).
D) Systemic transdermal estrogen patches.
Answer: C
Rationale: The patient exhibits classic signs of genitourinary syndrome
of menopause (GSM), formerly called vulvovaginal atrophy. When
symptoms are strictly localized to the vulvovaginal tissues and
, systemic vasomotor symptoms are absent, topical vaginal estrogen is
the gold-standard treatment. It restores vaginal tissue thickness,
decreases pH, and alleviates dyspareunia with minimal systemic
absorption. Over-the-counter moisturizers provide temporary comfort
but do not reverse tissue atrophy. Systemic oral or transdermal
estrogens are unnecessary and carry higher systemic risks.
4. A nurse-midwife evaluates a patient 30 minutes after a normal
spontaneous vaginal delivery of a 9 lb 4 oz infant. On assessment,
the nurse notes heavy vaginal bleeding with large clots. The
uterine fundus is palpated above the umbilicus and feels soft and
boggy. What is the most immediate and appropriate initial nursing
action?
A) Administer 0.2 mg of intramuscular methylergonovine
(Methergine).
B) Perform vigorous bimanual uterine massage and check for
bladder distension.
C) Call the surgical team immediately for an emergency
hysterectomy.
D) Start an immediate blood transfusion of uncrossed O-negative
packed red blood cells.
Answer: B
Rationale: The patient is experiencing postpartum hemorrhage
secondary to uterine atony, which is the most common cause of early
postpartum bleeding (often exacerbated by a large infant). The
immediate first step is to perform uterine massage to stimulate
myometrial contractions and express clots. Simultaneously, checking
for a distended bladder is crucial because a full bladder displaces the
uterus upward and prevents effective contraction. Uterotonics like
EDITION COMPLETE TEST BANK — ALL
CHAPTERS 1-35 (LATEST 2026 UPDATE)
This comprehensive practice question pack mirrors
the official test bank structure across all 35
chapters of Gynecologic Health Care: With an
Introduction to Prenatal and Postpartum Care (4th
Edition). Each advanced multiple-choice question
features full diagnostic breakdowns, realistic clinical
scenarios, and bolded rationales targeting key
NCLEX and midwifery certification concepts. It
serves as an essential, high-yield resource for
nursing, nurse-midwifery, and nurse practitioner
students preparing for demanding clinical exams and
board certifications.
1. A 26-year-old female presents for her routine well-woman exam.
She has no significant medical history, no new sexual partners, and
her last cervical cancer screening was 3 years ago with normal
cytology. According to current ASCCP and ACOG guidelines, what
is the most appropriate next step in her cervical cancer screening
, management?
A) Rescreen with cytology alone in 2 years.
B) Screen with co-testing (cytology plus high-risk HPV testing)
today.
C) Screen with primary human papillomavirus (hpv) testing alone
today.
D) Delay all screening until she reaches age 30.
Answer: C
Rationale: For individuals aged 25 to 65, current primary guidelines
recommend screening every 5 years with primary HPV testing alone.
Alternatively, co-testing every 5 years or cytology alone every 3 years
is acceptable. Because she is 26 and her last pap was 3 years ago, she
is due for screening now. Primary HPV testing is preferred by major
clinical bodies due to its higher sensitivity for detecting cervical
intraepithelial neoplasia. Screening should not be delayed until age
30, nor should she wait another 2 years.
2. A 32-year-old G2P1 patient at 28 weeks of gestation presents to
the clinic for a routine prenatal visit. Her blood type is confirmed
as A-negative, and her antibody screen is negative. Her husband’s
blood type is unknown. Which clinical intervention is indicated at
this visit?
A) Administer Rho(D) immune globulin (RhoGAM) 300 mcg
intramuscularly today.
B) Hold RhoGAM until delivery and test the infant’s cord blood
first.
C) Perform a Kleihauer-Betke test to quantify fetal-maternal
hemorrhage before treating.
, D) Administer RhoGAM only if the patient experiences abdominal
trauma or vaginal bleeding.
Answer: A
Rationale: Prophylactic Rho(D) immune globulin (300 mcg) is routinely
administered to all unsensitized Rh-negative pregnant individuals
between 28 and 30 weeks of gestation. This prevents
alloimmunization in case the fetus is Rh-positive. Waiting until
delivery is unsafe because significant silent fetal-maternal
microhemorrhages can occur during the third trimester. A Kleihauer-
Betke test is used to calculate extra dosing after known trauma or
delivery, not for routine prophylaxis. Prophylaxis is standard
regardless of whether overt trauma has occurred.
3. A 53-year-old menopausal patient complains of severe
vulvovaginal burning, dryness, and dyspareunia. Physical
examination reveals pale, thin vaginal mucosa with a loss of
vaginal rugae and a vaginal pH of 6.0. She has no vasomotor
symptoms or systemic medical contraindications. What is the first-
line, gold-standard therapy for this specific condition?
A) Low-dose oral conjugated estrogens.
B) Vaginal moisturizers and water-based lubricants.
C) Topical low-dose vaginal estrogen therapy (cream, tablet, or
ring).
D) Systemic transdermal estrogen patches.
Answer: C
Rationale: The patient exhibits classic signs of genitourinary syndrome
of menopause (GSM), formerly called vulvovaginal atrophy. When
symptoms are strictly localized to the vulvovaginal tissues and
, systemic vasomotor symptoms are absent, topical vaginal estrogen is
the gold-standard treatment. It restores vaginal tissue thickness,
decreases pH, and alleviates dyspareunia with minimal systemic
absorption. Over-the-counter moisturizers provide temporary comfort
but do not reverse tissue atrophy. Systemic oral or transdermal
estrogens are unnecessary and carry higher systemic risks.
4. A nurse-midwife evaluates a patient 30 minutes after a normal
spontaneous vaginal delivery of a 9 lb 4 oz infant. On assessment,
the nurse notes heavy vaginal bleeding with large clots. The
uterine fundus is palpated above the umbilicus and feels soft and
boggy. What is the most immediate and appropriate initial nursing
action?
A) Administer 0.2 mg of intramuscular methylergonovine
(Methergine).
B) Perform vigorous bimanual uterine massage and check for
bladder distension.
C) Call the surgical team immediately for an emergency
hysterectomy.
D) Start an immediate blood transfusion of uncrossed O-negative
packed red blood cells.
Answer: B
Rationale: The patient is experiencing postpartum hemorrhage
secondary to uterine atony, which is the most common cause of early
postpartum bleeding (often exacerbated by a large infant). The
immediate first step is to perform uterine massage to stimulate
myometrial contractions and express clots. Simultaneously, checking
for a distended bladder is crucial because a full bladder displaces the
uterus upward and prevents effective contraction. Uterotonics like
